Gastro-intestinal Physiology After Anti-Reflux Procedures
Launched by ST GEORGE'S, UNIVERSITY OF LONDON · Feb 11, 2022
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
GORD is caused by backflow of stomach contents, including acid and bile into the oesophagus. It can lead to distressing symptoms such as heartburn, regurgitation, and chest pain. It is more common in men, smokers, advanced age, obesity and consumption of fatty foods and alcohol. The mechanism of GORD can be complex and multifactorial. The best appreciated mechanism is reduced pressure of the lower oesophageal sphincter (LOS) or excessive transeient relaxations of the LOS (TLOSR), which allows stomach contents to reflux into the oesophagus. Hiatus hernia can cause GORD by a similar mechanism...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient under the care of St George's University Hospital NHS Foundation Trust, London
- • Decision to specifically undergo Stretta procedure, laparoscopic fundoplication or LINX device (N.B. this study will have no involvement in that decision or choice of procedure)
- • Symptoms compatible with GORD, e.g. heartburn, regurgitation, chest pain
- • Physiological evidence of GORD, e.g. endoscopy, HRM, pH studies
- • Male or Female
- • Age 18 to 90
- Exclusion Criteria:
- • Patients \< 18 years old or \>90 years old
- • Patients with significant medical co-morbidities
- • Patients unable to provide consent for study participation
- • Patients unable to easily attend hospital for the physiological tests
- • Patients who have had complications from their anti-reflux procedure
- • Patients who have previously undergone oesophageal surgery
About St George's, University Of London
St George's, University of London is a leading academic institution dedicated to advancing healthcare through innovative research and education. As a prominent clinical trial sponsor, the university leverages its expertise in biomedical sciences, medicine, and health professions to conduct rigorous clinical studies aimed at improving patient outcomes. With a commitment to ethical practices and collaboration across disciplines, St George's fosters an environment that encourages groundbreaking discoveries and the translation of research findings into clinical applications, ultimately enhancing the quality of care in diverse medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Jamal Hayat
Study Director
St George's University Hospitals NHS Foundation Trust
Joseph Cooney
Principal Investigator
St George's University Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials